Tag: IP strategy drug development
Patent Term Extensions Explained: Complete Guide to Pharma IP Strategy, Global Rules, and Compliance 2025
Patent Term Extensions Explained: Complete Guide to Pharma IP Strategy, Global Rules, and Compliance 2025 Patent Term Extensions in Pharma: Strategies for Lifecycle Management and Global Compliance Introduction to Patent Term Extensions Patent term extensions (PTEs) are mechanisms that extend the life of pharmaceutical patents to compensate innovators for time lost during regulatory approval processes. Drug development and regulatory review often consume a significant portion of patent life, leaving limited market exclusivity for innovators to recover R&D costs. To address this, regulators in the US, EU, and other jurisdictions allow patent extensions under specific rules. By 2025, PTEs remain an…
